Ca<sub>v</sub>2.1 | Voltage-gated calcium channels | IUPHAR/BPS Guide to PHARMACOLOGY

Top ▲

Cav2.1

Target id: 532

Nomenclature: Cav2.1

Family: Voltage-gated calcium channels

Annotation status:  image of a green circle Annotated and expert reviewed. Please contact us if you can help with updates.  » Email us

   GtoImmuPdb view: OFF :     Currently no data for Cav2.1 in GtoImmuPdb

Gene and Protein Information
Species TM P Loops AA Chromosomal Location Gene Symbol Gene Name Reference
Human 24 0 2512 19p13.2-p13.1 CACNA1A calcium voltage-gated channel subunit alpha1 A
Mouse 24 0 2368 8 C3 Cacna1a calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
Rat 24 0 2368 19q11 Cacna1a calcium voltage-gated channel subunit alpha1 A
Previous and Unofficial Names
α1A | APCA | CACNL1A4 | FHM | HPCA | MHP1 | BccA1 | brain calcium channel 1 | RBA-I | alpha1A | Ccha1a | SCA6 | calcium channel
Database Links
ChEMBL Target
DrugBank Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Gene
OMIM
Orphanet
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia
Associated Proteins
Heteromeric Pore-forming Subunits
Name References
Not determined
Auxiliary Subunits
Name References
β1-4 52
α 52
Other Associated Proteins
Name References
Not determined
Functional Characteristics
P/Q-type calcium current: Moderate voltage-activated, moderate voltage-dependent inactivation
Ion Selectivity and Conductance
Species:  Human
Rank order:  Ba2+ [16.3 - 19.6 (median: 19.5) pS]
References:  26,92,105
Species:  Mouse
Rank order:  Ba2+ [9.0 - 17.0 (median: 14.0) pS]
References:  17
Species:  Rat
Rank order:  Ba2+ [16.5 - 17.2 pS]
References:  7
Ion Selectivity and Conductance Comments
Murine channels in cerebellar Purkinje cells were found to have 3 distinct conductance levels at 9, 14 and 17pS [17].
Voltage Dependence
  V0.5 (mV)  τ (msec)  Reference  Cell type  Species 
Activation  9.5 0.6 – 2.2 27 HEK 293 cells. Human
Inactivation  -17.0 690.0 – 148.0 27
  V0.5 (mV)  τ (msec)  Reference  Cell type  Species 
Activation  -10.1 – 2.1 (median: -4.1) 3.3 7,87 Xenopus laevis oocyte Rat
Inactivation  -45.3 – -1.6 (median: -29.2) - 7,87
  V0.5 (mV)  τ (msec)  Reference  Cell type  Species 
Activation  -16.2 – -4.3 (median: -9.0) 0.79 51,63 Neurons (neostriatal, cortical and mossy fibres) Rat
Inactivation  - 0.09 – 1000.0 51,63
Voltage Dependence Comments
The rates of Cav2.1 inactivation and V0.5,inact are differentially affected by co-expression with β1, β2, β3 and β4 subunits, as well as by alternative splicing of Cav2.1. Whole cell currents with slow P-type kinetics appear to be conducted by splice variants co-expressed with the β2 subunit. Whole cell currents with Q-type kinetics appear to be encoded by Cav2.1 co-expressed with and of the β1, β3 or β4 subunits [63,87].

Download all structure-activity data for this target as a CSV file

Gating inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Concentration range (M) Holding voltage (mV) Reference
ω-agatoxin IIIA Rn - 9.3 pKd - -80.0 59,64
pKd 9.3 [59,64]
Holding voltage: -80.0 mV
ω-agatoxin IVB Rn - 8.5 pKd - -80.0 1
pKd 8.5 (Kd 3x10-9 M) [1]
Holding voltage: -80.0 mV
kurtoxin Rn Antagonist 7.8 pEC50 - -80.0 78
pEC50 7.8 [78]
Holding voltage: -80.0 mV
ω-agatoxin IVA Rn - 7.0 – 8.7 pIC50 - -100.0 – -90.0 7,67
pIC50 7.0 – 8.7 (IC50 1x10-7 – 2x10-9 M) P current component: Kd =~2nM, Q component Kd= >100nM [7,67]
Holding voltage: -100.0 – -90.0 mV
ω-grammotoxin SIA Rn Antagonist 6.7 – 7.1 pIC50 - Physiological 47,60
pIC50 6.7 – 7.1 [47,60]
Holding voltage: Physiological
mibefradil Rn - 6.5 pIC50 - -100.0 37
pIC50 6.5 [37]
Holding voltage: -100.0 mV
Gating Inhibitor Comments
Alternative splicing of Cav2.1 alters sensitivity to ω-agatoxin IVA. Whole cell currents with Q-type pharmacology appear encoded by Cav splice variants containing Asp-Pro residues in the domain IV S3-S4 linker, while whole cell currents with P-type pharmacology appear encoded by Cav splice variants missing Asp-Pro residues in residues in domain IV S3-S4 linker. ω-agatoxin IVA exhibits ~10-fold difference in IC50 between P-type and Q-type channels [7].

ω-grammotoxin SIA causes a +110mV shift in the voltage dependence of Cav2.1 channels [60].

Notable Cav splice variants with physiological and/or pharmacological differences are found in refs [7,12,76,82,94].
Channel Blockers
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Concentration range (M) Holding voltage (mV) Reference
Ni2+ Rn - - - 1x10-4 - 1x10-3 -100.0 110
Conc range: 1x10-4 - 1x10-3 M [110]
Holding voltage: -100.0 mV
ω-PnTx3-3 Rn - - - 6x10-8 -80.0 50
Conc range: 6x10-8 M [50]
Holding voltage: -80.0 mV
ω-phonetoxin-IIA Rn - 9.2 pKd - -80.0 11
pKd 9.2 [11]
Holding voltage: -80.0 mV
DW13.3 Rn - 8.4 pEC50 - -100.0 88
pEC50 8.4 [88]
Holding voltage: -100.0 mV
ω-conotoxin MVIID Bt - 9.0 pIC50 - Physiological
pIC50 9.0
Holding voltage: Physiological
ω-conotoxin MVIIC Rn - 8.2 – 9.2 pIC50 2x10-6 - 5x10-6 Physiological 49
pIC50 8.2 – 9.2 (IC50 7x10-9 – 6x10-10 M) Conc range: 2x10-6 - 5x10-6 M [49]
Holding voltage: Physiological
ω-conotoxin CVIB Rn Antagonist 8.0 pIC50 - Physiological 49
pIC50 8.0 [49]
Holding voltage: Physiological
ω-conotoxin CVIC Rn Antagonist 7.5 pIC50 - Physiological 49
pIC50 7.5 [49]
Holding voltage: Physiological
PnTx-3-6 Rn - 6.6 pIC50 - -100.0 102
pIC50 6.6 [102]
Holding voltage: -100.0 mV
ω-conotoxin MVIIA Rn Antagonist 6.3 pIC50 - Physiological 49
pIC50 6.3 [49]
Holding voltage: Physiological
Cd2+ Oc - 6.0 – 6.3 pIC50 - -80.0 – -60.0
pIC50 6.0 – 6.3
Holding voltage: -80.0 – -60.0 mV
ω-conotoxin CVIA Rn Antagonist 6.1 pIC50 - Physiological 49
pIC50 6.1 [49]
Holding voltage: Physiological
ω-conotoxin GVIA Rn Antagonist 6.0 pIC50 - Physiological 49
pIC50 6.0 [49]
Holding voltage: Physiological
ω-conotoxin CVID Rn Antagonist 4.2 pIC50 - Physiological 49
pIC50 4.2 [49]
Holding voltage: Physiological
View species-specific channel blocker tables
Channel Blocker Comments
For further information and data on the role of ω-conotoxin MVIIC as a channel blocker of Cav2.1 see the following references: [7,30,61,87]. In addition, there exist a large number of non-specific small organic blockers of native and exogenously expressed P/Q-type currents [70].
Tissue Distribution
Brain (hippocampus, entorhinal cortex, subiculum)
Species:  Human
Technique:  In situ hybridisation
References:  14
Brain (widespread)
Species:  Human
Technique:  Microarray analysis
References:  29
Brain (widespread)
Species:  Mouse
Technique:  In situ hybridisation
References:  48
Brain (cerebral cortex: neurons, oligodendrocyte precursor cells, newly formed oligodendrocytes, microglia, endothelial cells)
Species:  Mouse
Technique:  RNA transcriptome
References:  111
Auditory system (spiral ganglion)
Species:  Mouse
Technique:  qRT-PCR, immunocytochemistry
References:  13
Kidney (vascular smooth muscle, mesangial cells)
Species:  Rat
Technique:  RT-PCR and immunocytochemistry
References:  28
Brain (cerebellum > hippocampus, olfactory bulb > spinal cord, pons/medulla, striatum, hypothalamus/thalamus, cortex)
Species:  Rat
Technique:  Northern Blot
References:  81,86
Sperm
Species:  Rat
Technique:  Immunocytochemistry
References:  106
Brain (widespread, particularly cerebellum, hippocampus, cortex, olfactory bulb > hypothalamus, thalamus)
Species:  Rat
Technique:  In situ hybridisation
References:  53,87
Brain (hippocampus, cerebellum, dorsal cortex, olfactory bulb) and spinal cord
Species:  Rat
Technique:  Immunocytochemistry
References:  107-108
Vascular myocytes
Species:  Rat
Technique:  RT-PCR
References:  5
Pituitary (somatotrophs, lactotrophs)
Species:  Rat
Technique:  RT-PCR, immunocytochemistry, whole cell patch clamp
References:  86,97
Functional Assays
Patch-clamp (whole cell configuration)
Species:  Rat
Tissue:  Tissue slices (hippocampus or cerebellum)
Response measured:  P/Q-type currents
References:  51,74
Patch-clamp (whole cell-configuration)
Species:  Rat
Tissue:  Dissociated primary neurons (central and peripheral)
Response measured:  P/Q-type currents
References:  63,65,72-73
Patch clamp (whole-cell configuration)
Species:  Rat
Tissue:  Xenopus laevis oocytes expressing Cav2.1.
Response measured:  P/Q type currents
References:  87
Patch clamp (whole cell configuration)
Species:  Rat
Tissue:  HEK-293 cells expressing Cav2.1
Response measured:  P/Q-type currents
References:  7
Patch-clamp (whole cell configuration)
Species:  Human
Tissue:  HEK-293 cells expressing Cav2.1
Response measured:  P/Q-type current
References:  27
Patch-clamp (single channel recordings and two-microelectrode voltage clamp)
Species:  Rat
Tissue:  Xenopus laevis oocytes expressing Cav2.1
Response measured:  P/Q-type currents
References:  7
Measurement of intracellular calcium levels using fluorescent indicators
Species:  Rat
Tissue:  Primary neurons (dissociated and slice cultures)
Response measured:  Changes in intracellular calcium levels due to P/Q-type currents
References:  66
Measurement of evoked neurotransmitter release
Species:  Rat
Tissue:  Central neurons and synaptosomes
Response measured:  KCl-evoked release of neurotransmitters by activation of presynaptic P/Q-type channels
References:  54,95-96
Physiological Functions
Fast synaptic transmission and synaptic plasticity
Species:  Rat
Tissue:  Central neurons
References:  30,68,89,95
Neuromuscular transmission, acetylcholine release
Species:  Mouse
Tissue:  Motor nerve terminals
References:  8,98
Acute inflammatory pain
Species:  Rat
Tissue:  Brain and spinal cord
References:  55,79-80
Fast synaptic transmission and synaptic plasticity
Species:  Mouse
Tissue:  Central neurons
References:  25
Physiological Consequences of Altering Gene Expression
A transgenic mouse CACNA1A gene containing the R192Q mutation leads to enhanced presynaptic Ca2+ influx, decreased facilitation of evoked acetylcholine release, elevated release probability and increased size of the transmitter vesicle pool.
Species:  Mouse
Tissue:  Neuromuscular junction
Technique:  Knock-in
References:  39,101
Phenotypes, Alleles and Disease Models Mouse data from MGI

Show »

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Cacna1atg-la Cacna1atg-la/Cacna1atg-la
B6.Cg-Os +/+ Cacna1a/J
MGI:109482  MP:0005402 abnormal action potential PMID: 11718712 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0005332 abnormal amino acid level PMID: 6167317 
Cacna1atg-4J Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1a
MGI:109482  MP:0005404 abnormal axon morphology PMID: 18597946 
Cacna1a+|Cacna1atg-5J Cacna1atg-5J/Cacna1a+
B10(Cg)-Cacna1a
MGI:109482  MP:0005404 abnormal axon morphology PMID: 18597946 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0005404 abnormal axon morphology PMID: 10611370 
Cacna1atm1Fcr Cacna1atm1Fcr/Cacna1atm1Fcr
involves: 129S1/Sv * C57BL/6J
MGI:109482  MP:0002152 abnormal brain morphology PMID: 11344116 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0005277 abnormal brainstem morphology PMID: 6167317 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: C57BL/6J
MGI:109482  MP:0004994 abnormal brain wave pattern PMID: 10611370 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0000872 abnormal cerebellum external granule cell layer morphology PMID: 10611370 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0000849 abnormal cerebellum morphology PMID: 12023053  4799944 
Cacna1atm2Nobs Cacna1atm2Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0000849 abnormal cerebellum morphology PMID: 19854154 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
involves: 129P2/OlaHsd * C57BL/6J
MGI:109482  MP:0003484 abnormal channel response PMID: 15003170 
Cacna1atg-la Cacna1atg-la/Cacna1atg-la
B6.Cg-Os +/+ Cacna1a/J
MGI:109482  MP:0003484 abnormal channel response PMID: 11718712 
Cacna1atm1Hzo Cacna1atm1Hzo/Cacna1atm1Hzo
involves: 129S/SvEv
MGI:109482  MP:0003484 abnormal channel response PMID: 18687887 
Cacna1atm2Hzo Cacna1atm2Hzo/Cacna1atm2Hzo
involves: 129S/SvEv
MGI:109482  MP:0003484 abnormal channel response PMID: 18687887 
Cacna1atm3Hzo Cacna1atm3Hzo/Cacna1atm3Hzo
involves: 129S/SvEv
MGI:109482  MP:0003484 abnormal channel response PMID: 18687887 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0003484 abnormal channel response PMID: 10611370 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: C57BL/6J
MGI:109482  MP:0003484 abnormal channel response PMID: 10611370 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
involves: 129P2/OlaHsd * C57BL/6J
MGI:109482  MP:0002206 abnormal CNS synaptic transmission PMID: 15003170 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0002206 abnormal CNS synaptic transmission PMID: 12040045 
Cacna1atg Cacna1atg/Cacna1atg
involves: C57BL/6J * DBA/2J
MGI:109482  MP:0002206 abnormal CNS synaptic transmission PMID: 12151514 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: C57BL/6J
MGI:109482  MP:0002206 abnormal CNS synaptic transmission PMID: 10611370 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0005584 abnormal enzyme/coenzyme activity PMID: 6167317 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0002910 abnormal excitatory postsynaptic currents PMID: 12040045 
Cacna1atg Cacna1atg/Cacna1atg
B6.D2-Cacna1a/J
MGI:109482  MP:0002910 abnormal excitatory postsynaptic currents PMID: 12040045 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0002912 abnormal excitatory postsynaptic potential PMID: 10611370 
Cacna1arkr Cacna1arkr/Cacna1arkr
B6.Cg-Cacna1a
MGI:109482  MP:0001406 abnormal gait PMID: 11160387 
Cacna1a+|Cacna1aTg-7J Cacna1aTg-7J/Cacna1a+
involves: 129P2/OlaHsd * C57BL/6J
MGI:109482  MP:0001406 abnormal gait
Cacna1atg-rol|Cacna1atg Cacna1atg-rol/Cacna1atg
involves: C3H * C57BL/6 * DBA/2J * SIII
MGI:109482  MP:0001406 abnormal gait
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C3Hf/Nga * C57BL/6 * SIII
MGI:109482  MP:0002078 abnormal glucose homeostasis PMID: 1486501 
Cacna1a+|Cacna1atg-rol Cacna1atg-rol/Cacna1a+
involves: C3Hf/Nga * C57BL/6 * SIII
MGI:109482  MP:0002078 abnormal glucose homeostasis PMID: 1486501 
Cacna1atg-rol|Cacna1atg Cacna1atg-rol/Cacna1atg
involves: C3H * C57BL/6 * DBA/2J * SIII
MGI:109482  MP:0001392 abnormal locomotor activity
Cacna1arkr Cacna1arkr/Cacna1arkr
B6.Cg-Cacna1a
MGI:109482  MP:0003312 abnormal locomotor coordination PMID: 11160387 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0005266 abnormal metabolism PMID: 8229069 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
involves: 129P2/OlaHsd * C57BL/6J
MGI:109482  MP:0004835 abnormal miniature endplate potential PMID: 15003170 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0004753 abnormal miniature excitatory postsynaptic currents PMID: 12040045 
Cacna1atm1Fcr Cacna1atm1Fcr/Cacna1atm1Fcr
involves: 129S1/Sv * C57BL/6J
MGI:109482  MP:0002066 abnormal motor capabilities/coordination/movement PMID: 11344116 
Cacna1atm1Nobs Cacna1atm1Nobs/Cacna1atm1Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0002066 abnormal motor capabilities/coordination/movement PMID: 19854154 
Cacna1atm1Nobs|Cacna1atm2Nobs Cacna1atm1Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0002066 abnormal motor capabilities/coordination/movement PMID: 19854154 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0004145 abnormal muscle electrophysiology PMID: 18653245 
Cacna1atg-la Cacna1atg-la/Cacna1atg-la
B6.Cg-Os +/+ Cacna1a/J
MGI:109482  MP:0003477 abnormal nerve fiber response PMID: 11718712 
Cacna1atg-4J Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1a
MGI:109482  MP:0002272 abnormal nervous system electrophysiology PMID: 18597946 
Cacna1a+|Cacna1atg-5J Cacna1atg-5J/Cacna1a+
B10(Cg)-Cacna1a
MGI:109482  MP:0002272 abnormal nervous system electrophysiology PMID: 18597946 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0002272 abnormal nervous system electrophysiology PMID: 19104150 
Cacna1a+|Cacna1atm3Maag Cacna1atm3Maag/Cacna1a+
B6.129P2-Cacna1a
MGI:109482  MP:0002272 abnormal nervous system electrophysiology PMID: 19104150 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
B6.129P2-Cacna1a
MGI:109482  MP:0002272 abnormal nervous system electrophysiology PMID: 19104150 
Cacna1a+|Cacna1atm1Maag Cacna1atm1Maag/Cacna1a+
B6.129P2-Cacna1a
MGI:109482  MP:0002272 abnormal nervous system electrophysiology PMID: 19104150 
Cacna1atg-rol|Cacna1atg Cacna1atg-rol/Cacna1atg
involves: C3H * C57BL/6 * DBA/2J * SIII
MGI:109482  MP:0003632 abnormal nervous system morphology
Cacna1atm1Fcr Cacna1atm1Fcr/Cacna1atm1Fcr
involves: 129S1/Sv * C57BL/6J
MGI:109482  MP:0003633 abnormal nervous system physiology PMID: 11344116 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C3Hf/Nga * C57BL/6 * SIII
MGI:109482  MP:0003633 abnormal nervous system physiology PMID: 1486501 
Cacna1a+|Cacna1atg-rol Cacna1atg-rol/Cacna1a+
involves: C3Hf/Nga * C57BL/6 * SIII
MGI:109482  MP:0003633 abnormal nervous system physiology PMID: 1486501 
Cacna1atm3Hzo Cacna1atm3Hzo/Cacna1atm3Hzo
involves: 129S/SvEv
MGI:109482  MP:0002882 abnormal neuron morphology PMID: 18687887 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0002882 abnormal neuron morphology PMID: 10611370 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C3Hf/Nga * C57BL/6 * SIII
MGI:109482  MP:0003964 abnormal noradrenaline level PMID: 6123371 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0001382 abnormal nursing PMID: 4799944 
Cacna1atg Cacna1atg/Cacna1atg
B6.D2-Cacna1a/J
MGI:109482  MP:0004807 abnormal paired-pulse inhibition PMID: 12040045 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0008872 abnormal physiological response to xenobiotic PMID: 19104150 
Cacna1a+|Cacna1atm3Maag Cacna1atm3Maag/Cacna1a+
B6.129P2-Cacna1a
MGI:109482  MP:0008872 abnormal physiological response to xenobiotic PMID: 19104150 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
B6.129P2-Cacna1a
MGI:109482  MP:0008872 abnormal physiological response to xenobiotic PMID: 19104150 
Cacna1a+|Cacna1atm1Maag Cacna1atm1Maag/Cacna1a+
B6.129P2-Cacna1a
MGI:109482  MP:0008872 abnormal physiological response to xenobiotic PMID: 19104150 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
involves: 129P2/OlaHsd * C57BL/6J
MGI:109482  MP:0002913 abnormal PNS synaptic transmission PMID: 15003170 
Cacna1atm1Fcr Cacna1atm1Fcr/Cacna1atm1Fcr
involves: 129S1/Sv * C57BL/6J
MGI:109482  MP:0002089 abnormal postnatal growth/weight/body size PMID: 11344116 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0001504 abnormal posture PMID: 19104150 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
B6.129P2-Cacna1a
MGI:109482  MP:0001504 abnormal posture PMID: 19104150 
Cacna1arkr Cacna1arkr/Cacna1arkr
B6.Cg-Cacna1a
MGI:109482  MP:0008572 abnormal Purkinje cell dendrite morphology PMID: 11160387 
Cacna1atg-4J Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1a
MGI:109482  MP:0008572 abnormal Purkinje cell dendrite morphology PMID: 18597946 
Cacna1a+|Cacna1atg-5J Cacna1atg-5J/Cacna1a+
B10(Cg)-Cacna1a
MGI:109482  MP:0008572 abnormal Purkinje cell dendrite morphology PMID: 18597946 
Cacna1atg-4J Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1a
MGI:109482  MP:0000877 abnormal Purkinje cell morphology PMID: 18597946 
Cacna1a+|Cacna1atg-5J|Tg(Pvalb-EGFP)B20Zjh Cacna1atg-5J/Cacna1a+,Tg(Pvalb-EGFP)B20Zjh/?
involves: BALB/cByJ * C57BL/6 * C57BL/10J
MGI:109482  MGI:3803683  MP:0000877 abnormal Purkinje cell morphology PMID: 18597946 
Cacna1a+|Cacna1atg-5J Cacna1atg-5J/Cacna1a+
B10(Cg)-Cacna1a
MGI:109482  MP:0000877 abnormal Purkinje cell morphology PMID: 18597946 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0003638 abnormal response/metabolism to endogenous compounds PMID: 8229069 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: C57BL/6J
MGI:109482  MP:0008840 abnormal spike wave discharge PMID: 10611370 
Cacna1atm2Nobs Cacna1atm2Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0008840 abnormal spike wave discharge PMID: 19854154 
Cacna1atg-6J Cacna1atg-6J/Cacna1atg-6J
involves: BALB/cByJ * C57BL/6J
MGI:109482  MP:0002356 abnormal spleen red pulp morphology
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
involves: 129P2/OlaHsd * C57BL/6J
MGI:109482  MP:0004836 abnormal synaptic acetylcholine release PMID: 15003170 
Cacna1atm2.1Maag|Cacna1atm2.2Maag|Tg(EIIa-cre)C5379Lmgd Cacna1atm2.1Maag/Cacna1atm2.2Maag,Tg(EIIa-cre)C5379Lmgd/0
involves: 129P2/OlaHsd * FVB/N
MGI:109482  MGI:2137685  MP:0004836 abnormal synaptic acetylcholine release PMID: 17146767 
Cacna1atg-4J Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1a
MGI:109482  MP:0003491 abnormal voluntary movement PMID: 18597946 
Cacna1arkr Cacna1arkr/Cacna1arkr
B6.Cg-Cacna1a
MGI:109482  MP:0003216 absence seizures PMID: 11160387 
Cacna1atg-4J Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1a
MGI:109482  MP:0003216 absence seizures PMID: 18597946 
Cacna1atm2Nobs Cacna1atm2Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0003216 absence seizures PMID: 19854154 
Cacna1atm1Nobs|Cacna1atm2Nobs Cacna1atm1Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0003216 absence seizures PMID: 19854154 
Cacna1arkr Cacna1arkr/Cacna1arkr
B6.Cg-Cacna1a
MGI:109482  MP:0001393 ataxia PMID: 11160387 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0001393 ataxia PMID: 12040045  4799944 
Cacna1atm2.1Maag|Cacna1atm2.2Maag|Tg(EIIa-cre)C5379Lmgd Cacna1atm2.1Maag/Cacna1atm2.2Maag,Tg(EIIa-cre)C5379Lmgd/0
involves: 129P2/OlaHsd * FVB/N
MGI:109482  MGI:2137685  MP:0001393 ataxia PMID: 17146767 
Cacna1atg Cacna1atg/Cacna1atg
B6.D2-Cacna1a/J
MGI:109482  MP:0001393 ataxia PMID: 12040045 
Cacna1a+|Cacna1aWb Cacna1aWb/Cacna1a+
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0001393 ataxia PMID: 17376154 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0001393 ataxia PMID: 17376154 
Cacna1atg-la|Cacna1aWb Cacna1atg-la/Cacna1aWb
involves: AKR/J * C3H/HeJ * C57BL/6J
MGI:109482  MP:0001393 ataxia PMID: 17376154 
Cacna1atm1(CACNA1A)Ttan Cacna1atm1(CACNA1A)Ttan/Cacna1atm1(CACNA1A)Ttan
involves: 129S4/SvJae
MGI:109482  MP:0001393 ataxia PMID: 17188510 
Cacna1atm1.1(CACNA1A)Ttan Cacna1atm1.1(CACNA1A)Ttan/Cacna1atm1.1(CACNA1A)Ttan
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL
MGI:109482  MP:0001393 ataxia PMID: 17188510 
Cacna1atm2.1(CACNA1A)Ttan Cacna1atm2.1(CACNA1A)Ttan/Cacna1atm2.1(CACNA1A)Ttan
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL
MGI:109482  MP:0001393 ataxia PMID: 17188510 
Cacna1atg-4J Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1a
MGI:109482  MP:0001393 ataxia PMID: 18597946 
Cacna1atg-5J Cacna1atg-5J/Cacna1atg-5J
involves: BALB/cByJ * C57BL/10J
MGI:109482  MP:0001393 ataxia PMID: 18597946 
Cacna1a+|Cacna1atg-5J Cacna1atg-5J/Cacna1a+
B10(Cg)-Cacna1a
MGI:109482  MP:0001393 ataxia PMID: 18597946 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0001393 ataxia PMID: 10611370 
Cacna1atm1Nobs Cacna1atm1Nobs/Cacna1atm1Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0001393 ataxia PMID: 19854154 
Cacna1atm2Nobs Cacna1atm2Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0001393 ataxia PMID: 19854154 
Cacna1atm1Nobs|Cacna1atm2Nobs Cacna1atm1Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0001393 ataxia PMID: 19854154 
Cacna1a+|Cacna1aTg-7J Cacna1aTg-7J/Cacna1a+
involves: 129P2/OlaHsd * C57BL/6J
MGI:109482  MP:0001393 ataxia
Cacna1atg-rol|Cacna1atg Cacna1atg-rol/Cacna1atg
involves: C3H * C57BL/6 * DBA/2J * SIII
MGI:109482  MP:0001393 ataxia
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0000851 cerebellum hypoplasia
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0001394 circling PMID: 19104150 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
B6.129P2-Cacna1a
MGI:109482  MP:0001394 circling PMID: 19104150 
Cacna1atm2Nobs Cacna1atm2Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0003996 clonic seizures PMID: 19854154 
Cacna1atg-6J Cacna1atg-6J/Cacna1atg-6J
involves: BALB/cByJ * C57BL/6J
MGI:109482  MP:0001265 decreased body size
Cacna1atm2.1Maag|Cacna1atm2.2Maag|Tg(EIIa-cre)C5379Lmgd Cacna1atm2.1Maag/Cacna1atm2.2Maag,Tg(EIIa-cre)C5379Lmgd/0
involves: 129P2/OlaHsd * FVB/N
MGI:109482  MGI:2137685  MP:0001265 decreased body size PMID: 17146767 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0001265 decreased body size PMID: 17376154 
Cacna1atg-5J Cacna1atg-5J/Cacna1atg-5J
involves: BALB/cByJ * C57BL/10J
MGI:109482  MP:0001265 decreased body size PMID: 18597946 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0001265 decreased body size PMID: 10611370 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C3Hf/Nga * C57BL/6 * SIII
MGI:109482  MP:0001262 decreased body weight PMID: 1486501 
Cacna1atg-6J Cacna1atg-6J/Cacna1atg-6J
involves: BALB/cByJ * C57BL/6J
MGI:109482  MP:0000333 decreased bone marrow cell number
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0010053 decreased grip strength PMID: 17376154 
Cacna1atg-la|Cacna1aWb Cacna1atg-la/Cacna1aWb
involves: AKR/J * C3H/HeJ * C57BL/6J
MGI:109482  MP:0010053 decreased grip strength PMID: 17376154 
Cacna1atg-la Cacna1atg-la/Cacna1atg-la
B6.Cg-Os +/+ Cacna1a/J
MGI:109482  MP:0003481 decreased nerve fiber response intensity PMID: 11718712 
Cacna1atm2.1Maag|Cacna1atm2.2Maag|Tg(EIIa-cre)C5379Lmgd Cacna1atm2.1Maag/Cacna1atm2.2Maag,Tg(EIIa-cre)C5379Lmgd/0
involves: 129P2/OlaHsd * FVB/N
MGI:109482  MGI:2137685  MP:0003990 decreased neurotransmitter release PMID: 17146767 
Cacna1atg-la Cacna1atg-la/Cacna1atg-la
B6.Cg-Os +/+ Cacna1a/J
MGI:109482  MP:0003998 decreased thermal nociceptive threshold PMID: 11718712 
Cacna1atm3Hzo Cacna1atm3Hzo/Cacna1atm3Hzo
involves: 129S/SvEv
MGI:109482  MP:0001511 disheveled coat PMID: 18687887 
Cacna1atm2.1Maag|Cacna1atm2.2Maag|Tg(EIIa-cre)C5379Lmgd Cacna1atm2.1Maag/Cacna1atm2.2Maag,Tg(EIIa-cre)C5379Lmgd/0
involves: 129P2/OlaHsd * FVB/N
MGI:109482  MGI:2137685  MP:0005323 dystonia PMID: 17146767 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0005323 dystonia PMID: 17376154 
Cacna1atg-la|Cacna1aWb Cacna1atg-la/Cacna1aWb
involves: AKR/J * C3H/HeJ * C57BL/6J
MGI:109482  MP:0005323 dystonia PMID: 17376154 
Cacna1atm1(CACNA1A)Ttan Cacna1atm1(CACNA1A)Ttan/Cacna1atm1(CACNA1A)Ttan
involves: 129S4/SvJae
MGI:109482  MP:0005323 dystonia PMID: 17188510 
Cacna1atm1.1(CACNA1A)Ttan Cacna1atm1.1(CACNA1A)Ttan/Cacna1atm1.1(CACNA1A)Ttan
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL
MGI:109482  MP:0005323 dystonia PMID: 17188510 
Cacna1atm2.1(CACNA1A)Ttan Cacna1atm2.1(CACNA1A)Ttan/Cacna1atm2.1(CACNA1A)Ttan
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL
MGI:109482  MP:0005323 dystonia PMID: 17188510 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0009746 enhanced behavioral response to xenobiotic PMID: 19104150 
Cacna1a+|Cacna1atm3Maag Cacna1atm3Maag/Cacna1a+
B6.129P2-Cacna1a
MGI:109482  MP:0009746 enhanced behavioral response to xenobiotic PMID: 19104150 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
B6.129P2-Cacna1a
MGI:109482  MP:0009746 enhanced behavioral response to xenobiotic PMID: 19104150 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0002919 enhanced paired-pulse facilitation PMID: 12040045 
Cacna1a+|Cacna1aWb Cacna1aWb/Cacna1a+
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0001402 hypoactivity PMID: 17376154 
Cacna1atm3Hzo Cacna1atm3Hzo/Cacna1atm3Hzo
involves: 129S/SvEv
MGI:109482  MP:0001402 hypoactivity PMID: 18687887 
Cacna1atg-la Cacna1atg-la/Cacna1atg-la
B6.Cg-Os +/+ Cacna1a/J
MGI:109482  MP:0005498 hyporesponsive to tactile stimuli PMID: 11718712 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0001525 impaired balance PMID: 10611370 
Cacna1a+|Cacna1aWb Cacna1aWb/Cacna1a+
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0001405 impaired coordination PMID: 17376154 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0001405 impaired coordination PMID: 17376154 
Cacna1atg-la|Cacna1aWb Cacna1atg-la/Cacna1aWb
involves: AKR/J * C3H/HeJ * C57BL/6J
MGI:109482  MP:0001405 impaired coordination PMID: 17376154 
Cacna1a+|Cacna1atm1(CACNA1A)Ttan Cacna1atm1(CACNA1A)Ttan/Cacna1a+
involves: 129S4/SvJae
MGI:109482  MP:0001405 impaired coordination PMID: 17188510 
Cacna1atm3Hzo Cacna1atm3Hzo/Cacna1atm3Hzo
involves: 129S/SvEv
MGI:109482  MP:0001405 impaired coordination PMID: 18687887 
Cacna1a+|Cacna1atm3Hzo Cacna1atm3Hzo/Cacna1a+
involves: 129S/SvEv * C57BL/6J
MGI:109482  MP:0001405 impaired coordination PMID: 18687887 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0001405 impaired coordination PMID: 19104150 
Cacna1atm2Nobs Cacna1atm2Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0001405 impaired coordination PMID: 19854154 
Cacna1atg-6J Cacna1atg-6J/Cacna1atg-6J
involves: BALB/cByJ * C57BL/6J
MGI:109482  MP:0001524 impaired limb coordination
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0001524 impaired limb coordination PMID: 4799944 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0001523 impaired righting response PMID: 17376154 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0001523 impaired righting response PMID: 10611370 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0006042 increased apoptosis PMID: 12023053 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0009766 increased sensitivity to xenobiotic induced morbidity/mortality PMID: 19104150 
Cacna1atm2.1Maag|Cacna1atm2.2Maag|Tg(EIIa-cre)C5379Lmgd Cacna1atm2.1Maag/Cacna1atm2.2Maag,Tg(EIIa-cre)C5379Lmgd/0
involves: 129P2/OlaHsd * FVB/N
MGI:109482  MGI:2137685  MP:0008569 lethality at weaning PMID: 17146767 
Cacna1atm1(CACNA1A)Ttan Cacna1atm1(CACNA1A)Ttan/Cacna1atm1(CACNA1A)Ttan
involves: 129S4/SvJae
MGI:109482  MP:0008569 lethality at weaning PMID: 17188510 
Cacna1atm2(CACNA1A)Ttan Cacna1atm2(CACNA1A)Ttan/Cacna1atm2(CACNA1A)Ttan
involves: 129S4/SvJae
MGI:109482  MP:0008569 lethality at weaning PMID: 17188510 
Cacna1atm1.1(CACNA1A)Ttan Cacna1atm1.1(CACNA1A)Ttan/Cacna1atm1.1(CACNA1A)Ttan
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL
MGI:109482  MP:0008569 lethality at weaning PMID: 17188510 
Cacna1atm2.1(CACNA1A)Ttan Cacna1atm2.1(CACNA1A)Ttan/Cacna1atm2.1(CACNA1A)Ttan
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL
MGI:109482  MP:0008569 lethality at weaning PMID: 17188510 
Cacna1atg-6J Cacna1atg-6J/Cacna1atg-6J
involves: BALB/cByJ * C57BL/6J
MGI:109482  MP:0001513 limb grasping
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0000743 muscle spasm PMID: 10611370 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0000747 muscle weakness PMID: 18653245 
Cacna1atm2.1Maag Cacna1atm2.1Maag/Cacna1atm2.1Maag
involves: 129P2/OlaHsd
MGI:109482  MP:0002169 no abnormal phenotype detected PMID: 17146767 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0000753 paralysis PMID: 19104150 
Cacna1atm1Maag Cacna1atm1Maag/Cacna1atm1Maag
B6.129P2-Cacna1a
MGI:109482  MP:0000753 paralysis PMID: 19104150 
Cacna1atm1Nobs|Cacna1atm2Nobs Cacna1atm1Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0002082 postnatal lethality PMID: 19854154 
Cacna1atm1Fcr Cacna1atm1Fcr/Cacna1atm1Fcr
involves: 129S1/Sv * C57BL/6J
MGI:109482  MP:0002083 premature death PMID: 11344116 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0002083 premature death PMID: 17376154 
Cacna1atg-5J Cacna1atg-5J/Cacna1atg-5J
involves: BALB/cByJ * C57BL/10J
MGI:109482  MP:0002083 premature death PMID: 18597946 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0002083 premature death PMID: 10611370 
Cacna1atm1Nobs Cacna1atm1Nobs/Cacna1atm1Nobs
involves: 129 * C57BL/6J
MGI:109482  MP:0002083 premature death PMID: 19854154 
Cacna1atg-5J Cacna1atg-5J/Cacna1atg-5J
involves: BALB/cByJ * C57BL/10J
MGI:109482  MP:0002080 prenatal lethality PMID: 18597946 
Cacna1atg-5J Cacna1atg-5J/Cacna1atg-5J
B10(Cg)-Cacna1a
MGI:109482  MP:0002080 prenatal lethality PMID: 18597946 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0001923 reduced female fertility PMID: 4799944 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0001922 reduced male fertility PMID: 4799944 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0001953 respiratory failure PMID: 19104150 
Cacna1atm3Maag Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1a
MGI:109482  MP:0002064 seizures PMID: 19104150 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0000852 small cerebellum PMID: 6167317 
Cacna1a+|Cacna1aWb Cacna1aWb/Cacna1a+
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0000852 small cerebellum PMID: 17376154 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0000852 small cerebellum PMID: 17376154 
Cacna1atm1Hssh Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129/Sv * C57BL/6J
MGI:109482  MP:0000852 small cerebellum PMID: 10611370 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C3Hf/Nga * C57BL/6 * SIII
MGI:109482  MP:0000852 small cerebellum PMID: 6123371 
Cacna1a+|Cacna1aWb Cacna1aWb/Cacna1a+
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0000890 thin cerebellar molecular layer PMID: 17376154 
Cacna1aWb Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1a or (involves: C3H/HeJ * C57BL/6J)
MGI:109482  MP:0000890 thin cerebellar molecular layer PMID: 17376154 
Cacna1atg-6J Cacna1atg-6J/Cacna1atg-6J
involves: BALB/cByJ * C57BL/6J
MGI:109482  MP:0003644 thymus atrophy
Cacna1arkr Cacna1arkr/Cacna1arkr
B6.Cg-Cacna1a
MGI:109482  MP:0000745 tremors PMID: 11160387 
Cacna1atg-rol Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
MGI:109482  MP:0000746 weakness PMID: 4799944 
Clinically-Relevant Mutations and Pathophysiology
Disease:  Alternating hemiplegia of childhood 1; AHC1
Synonyms: Alternating hemiplegia of childhood [Orphanet: ORPHA2131] [Disease Ontology: DOID:0050635]
Disease Ontology: DOID:0050635
OMIM: 104290
Orphanet: ORPHA2131
References:  15
Disease:  Benign paroxysmal torticollis of infancy
Orphanet: ORPHA71518
References:  22,103
Click column headers to sort
Type Species Amino acid change Nucleotide change Description Reference
Missense Human E533K 103
Nonsense Human 5838C>G Nucleotide transversion at position 5838 results in a premature stop codon and truncated protein 22
Disease:  Episodic ataxia, type 2; EA2
Synonyms: Episodic ataxia [Disease Ontology: DOID:963]
Familial paroxysmal ataxia [Orphanet: ORPHA97]
Disease Ontology: DOID:963
OMIM: 108500
Orphanet: ORPHA97
Comments: 
References:  4,23,56
Click column headers to sort
Type Species Amino acid change Nucleotide change Description Reference
Frameshift: Deletion Human 780fs 2259-60delAG exon 16 16
Frameshift: Deletion Human 1293fs 3797delC exon 22 16
Frameshift: Deletion Human 1266fsX1333 4073delC (mRNA) exon 23 71
Frameshift: Duplication Human T898Lfs*170 2691dupC 40
In-frame deletion Human M1488-S1489del c.4739-44delDGTCCAT exon 28 57
In-frame deletion Human Y1594del and A1593D 4778-80delCTT exon 30. The 3 nucleotide deletion results in both an amino acid deletion and a substitution. 16
In-frame duplication Human H2220dup 6657_6659dupCCA 40
Missense Human E147K 31
Missense Human H253Y 100
Missense Human C256R 57
Missense Human C287Y 33,104
Missense Human G293R 33,104,109
Missense Human F1406C 33-34,36
Missense Human G1483R 57
Missense Human F1491S 24,57
Missense Human V1494I 57
Missense Human R1664Q 90
Missense Human R1666H 20
Missense Human H1736L 83
Missense Human E1761K 36
Missense Human R2136C 57
Nonsense Human R1279X 105
Nonsense Human R1281X 4077C>T exon 23 33-34,36
Nonsense Human Y1443X exon 27 16
Nonsense Human W1451X 4588G>A exon 27 33
Nonsense Human R1546X exon 29 16
Nonsense Human R1547X 35
Nonsense Human R1549X 4881C>T exon 29 33-34,36
Nonsense Human Q1561X 84
Nonsense Human R1669X 36
Nonsense Human R1785X 5589C>T exon 35 33
Nonsense Human R1820X 38
Nonsense Human Y1854X 5562C>G exon 37A 23
Nonsense Human R1858X 5571C>T exon 37A 23
Nonsense Human Q2039X 6351C>T exon 42 33
Splice site Human G4270+1A intron 24, results in aberrant splicing 71
Disease:  Migraine, familial hemiplegic, 1; FHM1
Synonyms: Familial hemiplegic migraine [Disease Ontology: DOID:0060178]
Familial or sporadic hemiplegic migraine [Orphanet: ORPHA569]
Disease Ontology: DOID:0060178
OMIM: 141500
Orphanet: ORPHA569
Comments: 
References:  2-4
Click column headers to sort
Type Species Amino acid change Nucleotide change Description Reference
Missense Human R192Q 9,26,39,45,62,71,101
Missense Human R195K 18
Missense Human S218L 44,93
Missense Human A405T 77
Missense Human R583Q 18,46
Missense Human T666M 6,9,18-19,26,42,45,71
Missense Human V714A 9,26,45,71
Missense Human D715E 18-19
Missense Human K1336E 18,69
Missense Human R1347Q 85
Missense Human Y1385C 19,99
Missense Human V1457L 10,46,92
Missense Human R1668W 19
Missense Human L1682P 21
Missense Human W1684R 18,69
Missense Human V1696I 18,69
Missense Human I1710T 43
Missense Human I1811L 9,26,45,71
Disease:  Spinocerebellar ataxia 6; SCA6
Synonyms: Spinocerebellar ataxia [Disease Ontology: DOID:1441]
Disease Ontology: DOID:1441
OMIM: 183086
Orphanet: ORPHA98758
Comments: 
References:  4
Click column headers to sort
Type Species Amino acid change Nucleotide change Description Reference
Splice variant Human Polyglutamine expansion in carboxyl region CAG repeat expansion 32,41,58,75,91
Clinically-Relevant Mutations and Pathophysiology Comments
FHM-1, EA-2 and SCA6 are all autosomal dominant disorders [4]

References

Show »

1. Adams ME, Mintz IM, Reily MD, Thanabal V, Bean BP. (1993) Structure and properties of omega-agatoxin IVB, a new antagonist of P-type calcium channels. Mol. Pharmacol., 44 (4): 681-8. [PMID:8232218]

2. Adams PJ, Garcia E, David LS, Mulatz KJ, Spacey SD, Snutch TP. (2009) Ca(V)2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies. Channels (Austin), 3 (2): 110-21. [PMID:19242091]

3. Adams PJ, Rungta RL, Garcia E, van den Maagdenberg AM, MacVicar BA, Snutch TP. (2010) Contribution of calcium-dependent facilitation to synaptic plasticity revealed by migraine mutations in the P/Q-type calcium channel. Proc. Natl. Acad. Sci. U.S.A., 107 (43): 18694-9. [PMID:20937883]

4. Adams PJ, Snutch TP. (2007) Calcium channelopathies: voltage-gated calcium channels. Subcell. Biochem., 45: 215-51. [PMID:18193639]

5. Andreasen D, Friis UG, Uhrenholt TR, Jensen BL, Skøtt O, Hansen PB. (2006) Coexpression of voltage-dependent calcium channels Cav1.2, 2.1a, and 2.1b in vascular myocytes. Hypertension, 47 (4): 735-41. [PMID:16505211]

6. Barrett CF, Cao YQ, Tsien RW. (2005) Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q-type calcium channel. J. Biol. Chem., 280 (25): 24064-71. [PMID:15795222]

7. Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, Snutch TP. (1999) Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat. Neurosci., 2 (5): 407-15. [PMID:10321243]

8. Bowersox SS, Miljanich GP, Sugiura Y, Li C, Nadasdi L, Hoffman BB, Ramachandran J, Ko CP. (1995) Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA. J. Pharmacol. Exp. Ther., 273 (1): 248-56. [PMID:7714772]

9. Cao YQ, Tsien RW. (2005) Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission. Proc. Natl. Acad. Sci. U.S.A., 102 (7): 2590-5. [PMID:15699344]

10. Carrera P, Piatti M, Stenirri S, Grimaldi LM, Marchioni E, Curcio M, Righetti PG, Ferrari M, Gelfi C. (1999) Genetic heterogeneity in Italian families with familial hemiplegic migraine. Neurology, 53 (1): 26-33. [PMID:10408532]

11. Cassola AC, Jaffe H, Fales HM, Castro Afeche S, Magnoli F, Cipolla-Neto J,. (1998) omega-phonetoxin-IIA: a calcium channel blocker from the spider phoneutria nigriventer. Pflugers Arch., 436 (4): 545-52. [PMID:9683727]

12. Chaudhuri D, Chang SY, DeMaria CD, Alvania RS, Soong TW, Yue DT. (2004) Alternative splicing as a molecular switch for Ca2+/calmodulin-dependent facilitation of P/Q-type Ca2+ channels. J. Neurosci., 24 (28): 6334-42. [PMID:15254089]

13. Chen WC, Xue HZ, Hsu YL, Liu Q, Patel S, Davis RL. (2011) Complex distribution patterns of voltage-gated calcium channel α-subunits in the spiral ganglion. Hear. Res., 278 (1-2): 52-68. [PMID:21281707]

14. Day NC, Shaw PJ, McCormack AL, Craig PJ, Smith W, Beattie R, Williams TL, Ellis SB, Ince PG, Harpold MM, Lodge D, Volsen SG. (1996) Distribution of alpha 1A, alpha 1B and alpha 1E voltage-dependent calcium channel subunits in the human hippocampus and parahippocampal gyrus. Neuroscience, 71 (4): 1013-24. [PMID:8684604]

15. de Vries B, Stam AH, Beker F, van den Maagdenberg AM, Vanmolkot KR, Laan L, Ginjaar IB, Frants RR, Lauffer H, Haan J et al.. (2008) CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood. Cephalalgia, 28 (8): 887-91. [PMID:18498393]

16. Denier C, Ducros A, Vahedi K, Joutel A, Thierry P, Ritz A, Castelnovo G, Deonna T, Gérard P, Devoize JL, Gayou A, Perrouty B, Soisson T, Autret A, Warter JM, Vighetto A, Van Bogaert P, Alamowitch S, Roullet E, Tournier-Lasserve E. (1999) High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology, 52 (9): 1816-21. [PMID:10371528]

17. Dove LS, Abbott LC, Griffith WH. (1998) Whole-cell and single-channel analysis of P-type calcium currents in cerebellar Purkinje cells of leaner mutant mice. J. Neurosci., 18 (19): 7687-99. [PMID:9742139]

18. Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, Darcel F, Vicaut E, Bousser MG, Tournier-Lasserve E. (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med., 345 (1): 17-24. [PMID:11439943]

19. Ducros A, Denier C, Joutel A, Vahedi K, Michel A, Darcel F, Madigand M, Guerouaou D, Tison F, Julien J, Hirsch E, Chedru F, Bisgård C, Lucotte G, Després P, Billard C, Barthez MA, Ponsot G, Bousser MG, Tournier-Lasserve E. (1999) Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am. J. Hum. Genet., 64 (1): 89-98. [PMID:9915947]

20. Friend KL, Crimmins D, Phan TG, Sue CM, Colley A, Fung VS, Morris JG, Sutherland GR, Richards RI. (1999) Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM. Hum. Genet., 105 (3): 261-5. [PMID:10987655]

21. Gardner K, BernalO, Keegan M, Badger J, Gerber O, Lowry N, Hoffman EP. (1999) A new mutation in the Chr19p calcium channel gene CACNLIA4 causing hemiplegic migraine with ataxia. Neurology, 52 (suppl. 2): A115.

22. Giffin NJ, Benton S, Goadsby PJ. (2002) Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol, 44 (7): 490-3. [PMID:12162387]

23. Graves TD, Imbrici P, Kors EE, Terwindt GM, Eunson LH, Frants RR, Haan J, Ferrari MD, Goadsby PJ, Hanna MG et al.. (2008) Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2. Neurobiol. Dis., 32 (1): 10-5. [PMID:18606230]

24. Guida S, Trettel F, Pagnutti S, Mantuano E, Tottene A, Veneziano L, Fellin T, Spadaro M, Stauderman K, Williams M, Volsen S, Ophoff R, Frants R, Jodice C, Frontali M, Pietrobon D. (2001) Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet., 68 (3): 759-64. [PMID:11179022]

25. Gundlfinger A, Bischofberger J, Johenning FW, Torvinen M, Schmitz D, Breustedt J. (2007) Adenosine modulates transmission at the hippocampal mossy fibre synapse via direct inhibition of presynaptic calcium channels. J. Physiol. (Lond.), 582 (Pt 1): 263-77. [PMID:17478533]

26. Hans M, Luvisetto S, Williams ME, Spagnolo M, Urrutia A, Tottene A, Brust PF, Johnson EC, Harpold MM, Stauderman KA, Pietrobon D. (1999) Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J. Neurosci., 19 (5): 1610-9. [PMID:10024348]

27. Hans M, Urrutia A, Deal C, Brust PF, Stauderman K, Ellis SB, Harpold MM, Johnson EC, Williams ME. (1999) Structural elements in domain IV that influence biophysical and pharmacological properties of human alpha1A-containing high-voltage-activated calcium channels. Biophys. J., 76 (3): 1384-400. [PMID:10049321]

28. Hansen PB, Jensen BL, Andreasen D, Friis UG, Skøtt O. (2000) Vascular smooth muscle cells express the alpha(1A) subunit of a P-/Q-type voltage-dependent Ca(2+)Channel, and It is functionally important in renal afferent arterioles. Circ. Res., 87 (10): 896-902. [PMID:11073885]

29. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, van de Lagemaat LN, Smith KA, Ebbert A, Riley ZL et al.. (2012) An anatomically comprehensive atlas of the adult human brain transcriptome. Nature, 489 (7416): 391-9. [PMID:22996553]

30. Hillyard DR, Monje VD, Mintz IM, Bean BP, Nadasdi L, Ramachandran J, Miljanich G, Azimi-Zoonooz A, McIntosh JM, Cruz LJ. (1992) A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron, 9 (1): 69-77. [PMID:1352986]

31. Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R, Kullmann DM, Hanna MG. (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain, 127 (Pt 12): 2682-92. [PMID:15483044]

32. Ishikawa K, Fujigasaki H, Saegusa H, Ohwada K, Fujita T, Iwamoto H, Komatsuzaki Y, Toru S, Toriyama H, Watanabe M, Ohkoshi N, Shoji S, Kanazawa I, Tanabe T, Mizusawa H. (1999) Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet., 8 (7): 1185-93. [PMID:10369863]

33. Jen J, Kim GW, Baloh RW. (2004) Clinical spectrum of episodic ataxia type 2. Neurology, 62 (1): 17-22. [PMID:14718690]

34. Jen J, Wan J, Graves M, Yu H, Mock AF, Coulin CJ, Kim G, Yue Q, Papazian DM, Baloh RW. (2001) Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology, 57 (10): 1843-8. [PMID:11723274]

35. Jen J, Yue Q, Nelson SF, Yu H, Litt M, Nutt J, Baloh RW. (1999) A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia. Neurology, 53 (1): 34-7. [PMID:10408533]

36. Jeng CJ, Chen YT, Chen YW, Tang CY. (2006) Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2. Am. J. Physiol., Cell Physiol., 290 (4): C1209-20. [PMID:16306128]

37. Jiménez C, Bourinet E, Leuranguer V, Richard S, Snutch TP, Nargeot J. (2000) Determinants of voltage-dependent inactivation affect Mibefradil block of calcium channels. Neuropharmacology, 39 (1): 1-10. [PMID:10665814]

38. Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM, Hanna MG. (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet, 358 (9284): 801-7. [PMID:11564488]

39. Kaja S, van de Ven RC, Broos LA, Veldman H, van Dijk JG, Verschuuren JJ, Frants RR, Ferrari MD, van den Maagdenberg AM, Plomp JJ. (2005) Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience, 135 (1): 81-95. [PMID:16111830]

40. Kipfer S, Jung S, Lemke JR, Kipfer-Kauer A, Howell JP, Kaelin-Lang A, Nyffeler T, Gutbrod K, Abicht A, Müri RM. (2013) Novel CACNA1A mutation(s) associated with slow saccade velocities. J. Neurol., 260 (12): 3010-4. [PMID:24046065]

41. Kordasiewicz HB, Thompson RM, Clark HB, Gomez CM. (2006) C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity. Hum. Mol. Genet., 15 (10): 1587-99. [PMID:16595610]

42. Kors EE, Haan J, Giffin NJ, Pazdera L, Schnittger C, Lennox GG, Terwindt GM, Vermeulen FL, Van den Maagdenberg AM, Frants RR, Ferrari MD. (2003) Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch. Neurol., 60 (5): 684-8. [PMID:12756131]

43. Kors EE, Melberg A, Vanmolkot KR, Kumlien E, Haan J, Raininko R, Flink R, Ginjaar HB, Frants RR, Ferrari MD, van den Maagdenberg AM. (2004) Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology, 63 (6): 1136-7. [PMID:15452324]

44. Kors EE, Terwindt GM, Vermeulen FL, Fitzsimons RB, Jardine PE, Heywood P, Love S, van den Maagdenberg AM, Haan J, Frants RR, Ferrari MD. (2001) Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol., 49 (6): 753-60. [PMID:11409427]

45. Kraus RL, Sinnegger MJ, Glossmann H, Hering S, Striessnig J. (1998) Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J. Biol. Chem., 273 (10): 5586-90. [PMID:9488686]

46. Kraus RL, Sinnegger MJ, Koschak A, Glossmann H, Stenirri S, Carrera P, Striessnig J. (2000) Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J. Biol. Chem., 275 (13): 9239-43. [PMID:10734061]

47. Lampe RA, Defeo PA, Davison MD, Young J, Herman JL, Spreen RC, Horn MB, Mangano TJ, Keith RA. (1993) Isolation and pharmacological characterization of omega-grammotoxin SIA, a novel peptide inhibitor of neuronal voltage-sensitive calcium channel responses. Mol. Pharmacol., 44 (2): 451-60. [PMID:8394998]

48. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ et al.. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature, 445 (7124): 168-76. [PMID:17151600]

49. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, Sharpe IA, Luchian T, Adams DJ, Bond T, Thomas L, Jones A, Matheson JL, Drinkwater R, Andrews PR, Alewood PF. (2000) Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J. Biol. Chem., 275 (45): 35335-44. [PMID:10938268]

50. Leão RM, Cruz JS, Diniz CR, Cordeiro MN, Beirão PS. (2000) Inhibition of neuronal high-voltage activated calcium channels by the omega-phoneutria nigriventer Tx3-3 peptide toxin. Neuropharmacology, 39 (10): 1756-67. [PMID:10884557]

51. Li L, Bischofberger J, Jonas P. (2007) Differential gating and recruitment of P/Q-, N-, and R-type Ca2+ channels in hippocampal mossy fiber boutons. J. Neurosci., 27 (49): 13420-9. [PMID:18057200]

52. Liu H, De Waard M, Scott VE, Gurnett CA, Lennon VA, Campbell KP. (1996) Identification of three subunits of the high affinity omega-conotoxin MVIIC-sensitive Ca2+ channel. J. Biol. Chem., 271 (23): 13804-10. [PMID:8662888]

53. Ludwig A, Flockerzi V, Hofmann F. (1997) Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain. J. Neurosci., 17 (4): 1339-49. [PMID:9006977]

54. Luebke JI, Dunlap K, Turner TJ. (1993) Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron, 11 (5): 895-902. [PMID:7902110]

55. Malmberg AB, Yaksh TL. (1994) Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci., 14 (8): 4882-90. [PMID:8046458]

56. Mantuano E, Romano S, Veneziano L, Gellera C, Castellotti B, Caimi S, Testa D, Estienne M, Zorzi G, Bugiani M et al.. (2010) Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J. Neurol. Sci., 291 (1-2): 30-6. [PMID:20129625]

57. Mantuano E, Veneziano L, Spadaro M, Giunti P, Guida S, Leggio MG, Verriello L, Wood N, Jodice C, Frontali M. (2004) Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit Ca(v)2.1 causing episodic ataxia 2. J. Med. Genet., 41 (6): e82. [PMID:15173248]

58. Matsuyama Z, Wakamori M, Mori Y, Kawakami H, Nakamura S, Imoto K. (1999) Direct alteration of the P/Q-type Ca2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J. Neurosci., 19 (12): RC14. [PMID:10366652]

59. McDonough SI, Boland LM, Mintz IM, Bean BP. (2002) Interactions among toxins that inhibit N-type and P-type calcium channels. J. Gen. Physiol., 119 (4): 313-28. [PMID:11929883]

60. McDonough SI, Lampe RA, Keith RA, Bean BP. (1997) Voltage-dependent inhibition of N- and P-type calcium channels by the peptide toxin omega-grammotoxin-SIA. Mol. Pharmacol., 52 (6): 1095-104. [PMID:9415720]

61. McDonough SI, Swartz KJ, Mintz IM, Boland LM, Bean BP. (1996) Inhibition of calcium channels in rat central and peripheral neurons by omega-conotoxin MVIIC. J. Neurosci., 16 (8): 2612-23. [PMID:8786437]

62. Melliti K, Grabner M, Seabrook GR. (2003) The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Ca(V)2.1) calcium channels expressed in human embryonic kidney cells. J. Physiol. (Lond.), 546 (Pt 2): 337-47. [PMID:12527722]

63. Mermelstein PG, Foehring RC, Tkatch T, Song WJ, Baranauskas G, Surmeier DJ. (1999) Properties of Q-type calcium channels in neostriatal and cortical neurons are correlated with beta subunit expression. J. Neurosci., 19 (17): 7268-77. [PMID:10460233]

64. Mintz IM. (1994) Block of Ca channels in rat central neurons by the spider toxin omega-Aga-IIIA. J. Neurosci., 14 (5 Pt 1): 2844-53. [PMID:8182443]

65. Mintz IM, Adams ME, Bean BP. (1992) P-type calcium channels in rat central and peripheral neurons. Neuron, 9 (1): 85-95. [PMID:1321648]

66. Mintz IM, Sabatini BL, Regehr WG. (1995) Calcium control of transmitter release at a cerebellar synapse. Neuron, 15 (3): 675-88. [PMID:7546746]

67. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, Adams ME. (1992) P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature, 355 (6363): 827-9. [PMID:1311418]

68. Mochida S, Few AP, Scheuer T, Catterall WA. (2008) Regulation of presynaptic Ca(V)2.1 channels by Ca2+ sensor proteins mediates short-term synaptic plasticity. Neuron, 57 (2): 210-6. [PMID:18215619]

69. Müllner C, Broos LA, van den Maagdenberg AM, Striessnig J. (2004) Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: evidence for beta-subunit isoform-specific effects. J. Biol. Chem., 279 (50): 51844-50. [PMID:15448138]

70. Nimmrich V, Gross G. (2012) P/Q-type calcium channel modulators. Br. J. Pharmacol., 167 (4): 741-59. [PMID:22670568]

71. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell, 87 (3): 543-52. [PMID:8898206]

72. Randall A, Tsien RW. (1995) Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. J. Neurosci., 15 (4): 2995-3012. [PMID:7722641]

73. Regan LJ, Sah DW, Bean BP. (1991) Ca2+ channels in rat central and peripheral neurons: high-threshold current resistant to dihydropyridine blockers and omega-conotoxin. Neuron, 6 (2): 269-80. [PMID:1847065]

74. Regehr WG, Mintz IM. (1994) Participation of multiple calcium channel types in transmission at single climbing fiber to Purkinje cell synapses. Neuron, 12 (3): 605-13. [PMID:8155322]

75. Restituito S, Thompson RM, Eliet J, Raike RS, Riedl M, Charnet P, Gomez CM. (2000) The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. J. Neurosci., 20 (17): 6394-403. [PMID:10964945]

76. Richards KS, Swensen AM, Lipscombe D, Bommert K. (2007) Novel CaV2.1 clone replicates many properties of Purkinje cell CaV2.1 current. Eur. J. Neurosci., 26 (10): 2950-61. [PMID:18001290]

77. Romaniello R, Zucca C, Tonelli A, Bonato S, Baschirotto C, Zanotta N, Epifanio R, Righini A, Bresolin N, Bassi MT et al.. (2010) A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J. Neurol. Neurosurg. Psychiatr., 81 (8): 840-3. [PMID:20682717]

78. Sidach SS, Mintz IM. (2002) Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels. J. Neurosci., 22 (6): 2023-34. [PMID:11896142]

79. Sluka KA. (1997) Blockade of calcium channels can prevent the onset of secondary hyperalgesia and allodynia induced by intradermal injection of capsaicin in rats. Pain, 71 (2): 157-64. [PMID:9211477]

80. Sluka KA. (1998) Blockade of N- and P/Q-type calcium channels reduces the secondary heat hyperalgesia induced by acute inflammation. J. Pharmacol. Exp. Ther., 287 (1): 232-7. [PMID:9765342]

81. Snutch TP, Leonard JP, Gilbert MM, Lester HA, Davidson N. (1990) Rat brain expresses a heterogeneous family of calcium channels. Proc. Natl. Acad. Sci. U.S.A., 87 (9): 3391-5. [PMID:1692134]

82. Soong TW, DeMaria CD, Alvania RS, Zweifel LS, Liang MC, Mittman S, Agnew WS, Yue DT. (2002) Systematic identification of splice variants in human P/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation. J. Neurosci., 22 (23): 10142-52. [PMID:12451115]

83. Spacey SD, Hildebrand ME, Materek LA, Bird TD, Snutch TP. (2004) Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann. Neurol., 56 (2): 213-20. [PMID:15293273]

84. Spacey SD, Materek LA, Szczygielski BI, Bird TD. (2005) Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch. Neurol., 62 (2): 314-6. [PMID:15710862]

85. Stam AH Vanmolkot KR Kremer HP Gärtner J Brown J Leshinsky-Silver E Gilad R Kors EE Frankhuizen WS Ginjaar HB Haan J Frants RR Ferrari MD van den Maagdenberg AM Terwindt GM. (2008) CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine. Clinical Genetics, Epub ahead of print (issue number): pages. [PMID:18400034]

86. Starr TV, Prystay W, Snutch TP. (1991) Primary structure of a calcium channel that is highly expressed in the rat cerebellum. Proc. Natl. Acad. Sci. U.S.A., 88 (13): 5621-5. [PMID:1648226]

87. Stea A, Tomlinson WJ, Soong TW, Bourinet E, Dubel SJ, Vincent SR, Snutch TP. (1994) Localization and functional properties of a rat brain alpha 1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proc. Natl. Acad. Sci. U.S.A., 91 (22): 10576-80. [PMID:7524096]

88. Sutton KG, Siok C, Stea A, Zamponi GW, Heck SD, Volkmann RA, Ahlijanian MK, Snutch TP. (1998) Inhibition of neuronal calcium channels by a novel peptide spider toxin, DW13.3. Mol. Pharmacol., 54 (2): 407-18. [PMID:9687583]

89. Takahashi T, Momiyama A. (1993) Different types of calcium channels mediate central synaptic transmission. Nature, 366 (6451): 156-8. [PMID:7901765]

90. Tonelli A, D'Angelo MG, Salati R, Villa L, Germinasi C, Frattini T, Meola G, Turconi AC, Bresolin N, Bassi MT. (2006) Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene. J. Neurol. Sci., 241 (1-2): 13-7. [PMID:16325861]

91. Toru S, Murakoshi T, Ishikawa K, Saegusa H, Fujigasaki H, Uchihara T, Nagayama S, Osanai M, Mizusawa H, Tanabe T. (2000) Spinocerebellar ataxia type 6 mutation alters P-type calcium channel function. J. Biol. Chem., 275 (15): 10893-8. [PMID:10753886]

92. Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher C, Pietrobon D. (2002) Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. U.S.A., 99 (20): 13284-9. [PMID:12235360]

93. Tottene A, Pivotto F, Fellin T, Cesetti T, van den Maagdenberg AM, Pietrobon D. (2005) Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J. Biol. Chem., 280 (18): 17678-86. [PMID:15743764]

94. Tsunemi T, Saegusa H, Ishikawa K, Nagayama S, Murakoshi T, Mizusawa H, Tanabe T. (2002) Novel Cav2.1 splice variants isolated from Purkinje cells do not generate P-type Ca2+ current. J. Biol. Chem., 277 (9): 7214-21. [PMID:11756409]

95. Turner TJ, Adams ME, Dunlap K. (1992) Calcium channels coupled to glutamate release identified by omega-Aga-IVA. Science, 258 (5080): 310-3. [PMID:1357749]

96. Turner TJ, Adams ME, Dunlap K. (1993) Multiple Ca2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. U.S.A., 90 (20): 9518-22. [PMID:8415733]

97. Tzour A, Sosial E, Meir T, Canello T, Naveh-Many T, Gabizon R, Nussinovitch I. (2013) Multiple pathways for high voltage-activated ca(2+) influx in anterior pituitary lactotrophs and somatotrophs. J. Neuroendocrinol., 25 (1): 76-86. [PMID:22882461]

98. Uchitel OD, Protti DA, Sanchez V, Cherksey BD, Sugimori M, Llinás R. (1992) P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc. Natl. Acad. Sci. U.S.A., 89 (8): 3330-3. [PMID:1348859]

99. Vahedi K, Denier C, Ducros A, Bousson V, Levy C, Chabriat H, Haguenau M, Tournier-Lasserve E, Bousser MG. (2000) CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology, 55 (7): 1040-2. [PMID:11061267]

100. van den Maagdenberg AM, Kors EE, Brunt ER, van Paesschen W, Pascual J, Ravine D, Keeling S, Vanmolkot KR, Vermeulen FL, Terwindt GM, Haan J, Frants RR, Ferrari MD. (2002) Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A gene. J. Neurol., 249 (11): 1515-9. [PMID:12420090]

101. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, van de Ven RC, Tottene A, van der Kaa J, Plomp JJ, Frants RR, Ferrari MD. (2004) A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron, 41 (5): 701-10. [PMID:15003170]

102. Vieira LB, Kushmerick C, Hildebrand ME, Garcia E, Stea A, Cordeiro MN, Richardson M, Gomez MV, Snutch TP. (2005) Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6. J. Pharmacol. Exp. Ther., 314 (3): 1370-7. [PMID:15933156]

103. Vila-Pueyo M, Gené GG, Flotats-Bastardes M, Elorza X, Sintas C, Valverde MA, Cormand B, Fernández-Fernández JM, Macaya A. (2014) A loss-of-function CACNA1A mutation causing benign paroxysmal torticollis of infancy. Eur. J. Paediatr. Neurol., 18 (3): 430-3. [PMID:24445160]

104. Wan J, Khanna R, Sandusky M, Papazian DM, Jen JC, Baloh RW. (2005) CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics. Neurology, 64 (12): 2090-7. [PMID:15985579]

105. Wappl E, Koschak A, Poteser M, Sinnegger MJ, Walter D, Eberhart A, Groschner K, Glossmann H, Kraus RL, Grabner M, Striessnig J. (2002) Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J. Biol. Chem., 277 (9): 6960-6. [PMID:11742003]

106. Westenbroek RE, Babcock DF. (1999) Discrete regional distributions suggest diverse functional roles of calcium channel alpha1 subunits in sperm. Dev. Biol., 207 (2): 457-69. [PMID:10068476]

107. Westenbroek RE, Hoskins L, Catterall WA. (1998) Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J. Neurosci., 18 (16): 6319-30. [PMID:9698323]

108. Westenbroek RE, Sakurai T, Elliott EM, Hell JW, Starr TV, Snutch TP, Catterall WA. (1995) Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels. J. Neurosci., 15 (10): 6403-18. [PMID:7472404]

109. Yue Q, Jen JC, Nelson SF, Baloh RW. (1997) Progressive ataxia due to a missense mutation in a calcium-channel gene. Am. J. Hum. Genet., 61 (5): 1078-87. [PMID:9345107]

110. Zamponi GW, Bourinet E, Snutch TP. (1996) Nickel block of a family of neuronal calcium channels: subtype- and subunit-dependent action at multiple sites. J. Membr. Biol., 151 (1): 77-90. [PMID:8661496]

111. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N et al.. (2014) An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. J. Neurosci., 34 (36): 11929-47. [PMID:25186741]

Contributors

Show »

How to cite this page

William A. Catterall, Edward Perez-Reyes, Terrance P. Snutch, Joerg Striessnig.
Voltage-gated calcium channels: Cav2.1. Last modified on 27/06/2016. Accessed on 20/11/2018. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=532.